2161 — Jbm (Healthcare) Income Statement
0.000.00%
Last trade - 00:00- HK$875.50m
- HK$919.37m
- HK$648.42m
- 93
- 89
- 29
- 85
Annual income statement for Jbm (Healthcare), fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 382 | 397 | 406 | 520 | 648 |
| Cost of Revenue | |||||
| Gross Profit | 190 | 198 | 162 | 206 | 338 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 330 | 347 | 367 | 433 | 474 |
| Operating Profit | 51.8 | 50.3 | 38.9 | 87 | 174 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 54 | 41.7 | 30.7 | 76.9 | 165 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 44.3 | 30.6 | 23.3 | 63.3 | 137 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 41 | 22.6 | 24.6 | 57.1 | 130 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 41 | 22.6 | 24.6 | 57.1 | 130 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.053 | 0.048 | 0.03 | 0.051 | 0.143 |
| Dividends per Share |